Stay updated on ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial
Sign up to get notified when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.

Latest updates to the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 added. Revision: v3.4.2 removed.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedA new Revision: v3.4.2 has been added and the prior operation-status notice (associated with Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding was added and the site revision was updated from v3.4.0 to v3.4.1, replacing the previous version; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a glossary toggle and a new 'Last Update Submitted that Met QC Criteria' label, along with updated capitalization for 'No FEAR Act Data' and a 'Revision: v3.4.0' entry, as minor UI/metadata updates. These do not alter core trial data, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a consolidated Locations section with state entries (Arizona, California, Maryland, Massachusetts), replacing the previous location blocks. Included revision note v3.3.3 and removed the HHS Vulnerability Disclosure link.SummaryDifference0.5%

Stay in the know with updates to ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.